EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study

S Di Molfetta, A Rossi, R Gesuita, A Faragalli, A Cutruzzolà, C Irace, N Minuto, D Pitocco, F Cardella, C Arnaldi, A Frongia, E Mozzillo und 4 weitere

Acta Diabetologica · 2024

DOI: 10.1007/s00592-024-02381-3 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Diabetologica, 2024. Verfasst von S Di Molfetta und 15 weiteren Autor:innen. Beteiligte Einrichtung: Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Precision and Regenerative Medicine and Ionian Area, Uni…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose, Patient Satisfaction, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli studi "Magna Graecia" di Catanzaro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate glucose metrics, device satisfaction and diabetes impact in adults with type 1 diabetes using different treatment modalities in a real-life setting in Italy.

Methods

This was a multicentre, nationwide, cross-sectional study. Candidates were consecutively evaluated for eligibility during their routine medical visit at the diabetes centre. Researchers collected comprehensive demographic, socioeconomic, anamnestic and clinical data, and administered the Diabetes Impact and Device Satisfaction scale.

Results

From 2021 to 2022, a total of 428 subjects, 45% males, with a median age of 32 years (IQR 23–47) were recruited in 11 participating centres from all over Italy. No differences in age, physical activity, and diabetes impact were found for the different treatment modalities. HCL/AHCL and SAP groups reported higher device satisfaction vs. MDI + SMBG and MDI + CGM ( p < 0.001). Subjects treated with HCL/AHCL exhibited significantly higher TIR and significantly lower time spent in hypoglycemia level 1, time spent in hyperglycemia, CV and GMI compared to MDI + CGM, and significantly higher TIR and significantly lower time spent in hypoglycemia level 2, time spent in hyperglycemia, and CV compared to SAP. Significant reduction in hypoglycemia level 2 was also found with PLGM compared to SAP. High education attainment was associated with optimal metabolic control.

Conclusion

Real-life use of advanced technologies for type 1 diabetes is associated with improved glucose metrics and device satisfaction. Education level also contributes to success of treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Blood GlucosePatient SatisfactionBlood Glucose Self-MonitoringHumansMaleFemaleAdultCross-Sectional StudiesMiddle AgedYoung AdultHypoglycemic AgentsItalyInsulin Infusion SystemsInsulinHypoglycemia

Stichwörter der Autor:innen

AdultsContinuous subcutaneous insulin infusionDevice satisfactionHybrid closed loopTime in rangeTreatmentType 1 diabetes

Substanzen

Blood GlucoseHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, 70124, Italy.
  • IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, 20157, Italy.
  • Department of Biomedical and Clinical Sciences, University of Milan, Milan, 20122, Italy.
  • Center of Epidemiology, Biostatistics and Medical Information Technology, Polytechnic University of Marche, Ancona, 60020, Italy.
  • Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, 88100, Italy.
  • Department of Health Science, University Magna Graecia, Catanzaro, 88100, Italy. irace@unicz.it.

Förderung

  • Università degli studi "Magna Graecia" di Catanzaro

Zitieren

APA

Molfetta, S. D., Rossi, A., Gesuita, R., Faragalli, A., Cutruzzolà, A., Irace, C., Minuto, N., Pitocco, D., Cardella, F., Arnaldi, C., Frongia, A., Mozzillo, E., Predieri, B., Fiorina, P., Giorgino, F., & Cherubini, V. (2024). Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study. Acta Diabetologica. https://doi.org/10.1007/s00592-024-02381-3

Vancouver

Molfetta SD, Rossi A, Gesuita R, Faragalli A, Cutruzzolà A, Irace C, et al. Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study. Acta Diabetologica. 2024. doi:10.1007/s00592-024-02381-3

BibTeX
@article{Molfetta2024,
  author = {Molfetta, S Di and Rossi, A and Gesuita, R and Faragalli, A and Cutruzzolà, A and Irace, C and Minuto, N and Pitocco, D and Cardella, F and Arnaldi, C and Frongia, A and Mozzillo, E and Predieri, B and Fiorina, P and Giorgino, F and Cherubini, V},
  title = {Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study},
  journal = {Acta Diabetologica},
  year = {2024},
  doi = {10.1007/s00592-024-02381-3}
}
Kostenlos starten →